Evaluation of NT-proBNP in children with heart failure younger than 3 years old

1. BUTNARIU A., IANCU M., SAMASCA G., CHIRA M., LUPAN I. Changes in NT-proBNP in young children with congenital heart malformations. LabMedicine 2014; 45:43-47.10.1309/LMAO4UY90YJQWKKPSearch in Google Scholar

2. PRONTERA C., ZUCCHELLI G.C., VITTORINI S., STORTI S., EMDIN M., CLERICO A. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Clin Chim Acta 2009; 400:70-73.10.1016/j.cca.2008.10.011Search in Google Scholar

3. ROSS R.D., BOLLINGER R.O., PINSKY W.W. Grading the severity of congestive heart failure in infants. Pediatr Cardiol 1992; 13:72-75.10.1007/BF00798207Search in Google Scholar

4. RUSCONI P.G., LUDWIG D.A., RATNASAMY C., MAS R., HARMON W.G., COLAN S.D., et al. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 2010; 160:776-783.10.1016/j.ahj.2010.07.012Search in Google Scholar

5. RATNASAMY C., KINNAMON D.D., LIPSHULTZ S.E., RUSCONI P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J 2008; 155:527-533.10.1016/j.ahj.2007.11.001Search in Google Scholar

6. ARQUES S. Contribution of natriuretic peptide testing and Doppler echocardiography at bedside to the diagnosis of acute heart failure. A practical overview. Minerva Cardioangiol 2012; 60:385-394.Search in Google Scholar

7. BUTNARIU A., ZAMFIR M., IANCU M., IACOB D., SAMASCA G., LUPAN I. Systolic and Diastolic Function in Congestive Heart Failure Pediatric Patients. Rom J Intern Med 2016:54:37–46.10.1515/rjim-2016-0004Search in Google Scholar

8. HINDERLITER A.L., BLUMENTHAL J.A., O’CONNER C., ADAMS K.F., DUPREE C.S., WAUGH R.A., et al. Independent prognostic value of echocardiography and N-terminal pro–B-type natriuretic peptide in patients with heart failure. Am Heart J 2008; 156:1191-1195.10.1016/j.ahj.2008.07.022Search in Google Scholar

9. R CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012. ISBN 3-900051-07-0.Search in Google Scholar

10. BAGGISH A.L., VAN KIMMENADE R.R., JANUZZI J.L. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 2008; 101:43-48.10.1016/j.amjcard.2007.11.019Search in Google Scholar

11. BAGGISH A.L., VAN KIMMENADE R.R., JANUZZI J.L. Amino-Terminal Pro-B-Type Natriuretic Peptide Testing and Prognosis in Patients with Acute Dyspnea, Including Those with Acute Heart Failure. Am J Cardiol 2008; 101:49A–55A.10.1016/j.amjcard.2007.11.020Search in Google Scholar

12. SUGIMOTO M., MANABE H., NAKAU K., FURUYA A., OKUSHIMA K., FUJIYASU H., et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. Correlation with the heart failure score and comparison with B-type natriuretic peptide. Circ J 2010; 74:998-1005.10.1253/circj.CJ-09-0535Search in Google Scholar

13. ŞAHIN M., PORTAKAL O., KARAGÖZ T., HASÇELIK G., ÖZKUTLU S. Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem 2010; 43:1278–1281.10.1016/j.clinbiochem.2010.08.002Search in Google Scholar

14. KANTOR P.F., RUSCONI P., LIPSHULTZ S., MITAL S., WILKINSON J.D., BURCH M. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the Second International Conference on Pediatric Cardiomyopathy. Prog Pediatr Cardiol 2011; 32:11–14.10.1016/j.ppedcard.2011.06.003Search in Google Scholar

15. WONG D.T., GEORGE K., WILSON J., MANLHIOT C., MCCRINDLE B.W., ADELI K., et al. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure. Am J Cardiol 2011; 107:573-578.10.1016/j.amjcard.2010.10.015Search in Google Scholar

16. SANTHANAKRISHNAN R., CHONG J.P., NG T.P., LING L.H., SIM D., LEONG K.T., et al. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail. 2012:14:1338-1347.10.1093/eurjhf/hfs130Search in Google Scholar

17. NIETHAMMER M., SIEBER M., VON HAEHLING S., ANKER S.D., MUNZEL T., HORSTICK G., et al. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 2008; 129:111–117.10.1016/j.ijcard.2007.05.061Search in Google Scholar

18. DE DENUS S., LAVOIE J., DUCHARME A., O'MEARA E., RACINE N., SIROIS M.G., et al. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction. Can J Cardiol 2012; 28:62-68.10.1016/j.cjca.2011.09.007Search in Google Scholar

19. SCHOU M., GUSTAFSSON F., CORELL P., KISTORP C.N., KJAER A., HILDEBRANDT P.R. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Am Heart J 2007; 154:123-129.10.1016/j.ahj.2007.04.002Search in Google Scholar

20. JANUZZI J.L. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use. Arch Cardiovasc Dis 2012; 105:40-50.10.1016/j.acvd.2011.10.007Search in Google Scholar

21. CANTINOTTI M., CLERICO A., MURZI M., VITTORINI S., EMDIN M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta. 2008; 390:12-22.10.1016/j.cca.2007.12.020Search in Google Scholar

22. JOHNS M.C., STEPHENSON C. Amino-terminal Pro-B-type natriuretic peptide testing in neonatal and pediatric patients. Am J Cardiol 2008; 101:76-81.10.1016/j.amjcard.2007.11.028Search in Google Scholar

23. LOWENTHAL A., CAMACHO B.V., LOWENTHAL S., NATAL-HERNANDEZ L., LISZEWSKI W., HILLS N.K., et al. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol 2012; 109:866-872.10.1016/j.amjcard.2011.10.049Search in Google Scholar

• A Practical Review of Diabetes Mellitus Type 2 Treatment in Primary Care

• Lupus-related protein-losing enteropathy associated with pseudo–pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine

• COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant

• The Frailty Phenotype in Hemodialysis Patients and its Association with Biochemical Markers of Mineral Bone Disorder, Inflammation and Nutrition

• Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still’s disease. Does terminology matter?

• Non secretory myeloma in young man mimicking the Gorham disease: case report and the literature review

• Association between admission blood glucose and prognosis in non-diabetic patients with first-ever acute myocardial infarction

• Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome

• Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren syndrome

• Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment

• Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas

• Systematic Approach to Celiac Disease: A Comprehensive Review for Primary Providers

• The role of thyroid hormones in carotid arterial wall remodeling in women

• Serum Uric Acid as a Predictor of cardio-and cerebro-vascular diseases in Maintenance Hemodialysis Patients

• Anti - Dense Fıne Speckled (DFS) Antibody: its staınıng pattern in indirect immunofluorescence and its clinical relevance

• Cardiac biomarkers alterations in patients with SARS-CoV-2 infection

• Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience

• Autoimmune Polyglandular Syndrome Type II presenting as Subacute Combined Degeneration of Spinal Cord: A Neuroendocrinology Crossroad

• Erratum for the paper Erfani A. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2015;53(4):304-14.